stella
LUPUSApril 2026Summary reviewed November 2026

Decision Aid Helps Lupus Patients Feel Confident About Treatment Choices

A computerized tool that walks lupus patients through medication options reduced confusion about treatment decisions and improved communication with doctors. Nearly 1 in 5 lupus patients felt unsure about their treatment choices before using the aid, but most felt confident afterward.

What the trial was testing

The IDEAL Strategy enrolled 1,895 patients with lupus. The study was sponsored by University of Alabama at Birmingham and tracked outcomes across the full group of patients who matched the trial's eligibility profile.

Researchers followed patients through treatment and into recovery, tracking the outcomes that mattered most for the disease being studied.

What the results showed

83% of patients felt their actual role in treatment decisions matched what they preferred.

The Lancet. Rheumatology · 2026 · NCT03735238

These findings — that felt their actual role in treatment decisions matched their preferred role — were published in the The Lancet. Rheumatology and represent the headline result of the study.

Researchers tracked outcomes across 1,895 patients enrolled in the trial. The result was consistent enough across the group that the team felt confident reporting it.

What this means for patients

For patients with lupus, this result changes the calculus on what to ask their care team about. Whether it changes day-to-day care depends on factors like disease subtype, prior treatments, and where the patient is in their care journey.

What you can do now

This tool helps you understand your lupus treatment options and have better conversations with your rheumatologist. It's designed to reduce confusion and let you play the role you want in deciding your care. The app (ManageMyLupus) is free and available now — ask your doctor if it's right for you.

Eligibility for the treatments mentioned above depends on specific test results and clinical history. Bring this summary, the trial name, and your most recent labs or pathology report to your next visit.